SEARCH

SEARCH BY CITATION

REFERENCES

  • Armstrong B, White E, Saracci R. 1992. Principles of exposure measurement in epidemiology. New York: Oxford University Press.
  • Armstrong BG. 1998. Effect of measurement error on epidemiological studies of environmental and occupational exposures. Occup Environ Med 55: 651656.
  • Aronson KJ, Miller AB, Woolcott CG, Sterns EE, McGready DR, Lickley LA, Fish EB, Hiraki GY, Holloway C, Ross T, Hanna WM, SenGupta SK, Weber JP. 2000. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9: 5563.
  • Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. 1993. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85: 11591164.
  • Berkowitz G, Kelsey J, LiVolsi V, Holford TMM, O'Connor T, White C. 1985. Risk factors for fibrocystic breast disease and its histopathologic components. J Natl Cancer Inst 75: 4350.
  • Calaf G, Russo J. 1993. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483492.
  • Curigliano G, Zhang Y, Wang L, Flamini G, Alcini A, Ratto C, Giustacchini M, Alcini E, Cittadini A, Santella R. 1996. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. Carcinogenesis 17: 911916.
  • Duffy S, Roberts M, Elton R. 1983. Risk factors relevant to cystic breast disease: a case-control study. J Epidemiol Commun Health 37: 271273.
  • El-Bayoumy K. 1992. Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol 5: 585590.
  • Eldridge SR, Gould MN, Butterworth BE. 1992. Genotoxicity of environmental agents in human mammary epithelial cells. Cancer Res 52: 56175621.
  • Elmore J, Wells C, Howard D, Feinstein A. 1997. The impact of clinical history on mammographic interpretations. JAMA 277: 4952.
  • Falck F, Ricci A, Wolff MS, Godbold J, Deckers P. 1992. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47: 143146.
  • Flanders W, DerSimonian R, Freedman D. 1992. Interpretation of linear regression models that include transformations or interaction terms. Ann Epidemiol 2: 735744.
  • Gammon M, Hibshoosh H, Terry M, Bose S, Schoenburg J, Brinton L, Bernstein J, Thompson W. 1999. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev 8: 255263.
  • Goehring C, Morabia A. 1997. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 19: 310327.
  • Hsieh C, Walker A, Trapido E, Crosson A, MacMahon S. 1984. Age at first birth and breast atypia. Int J Cancer 33: 309312.
  • Hsu T, Zhang Y, Santella RM. 1997. Immunoperoxidase quantitation of 4-aminobipheny- and polycylic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 6: 193199.
  • International Agency for Research on Cancer (IARC). 1983. Polynuclear aromatic compounds. Part 1. Chemical, environmental, and experimental data. IARC monographs on the evaluation on the carcinogenic risk of chemicals to humans (Vol. 32). Lyon, France: International Agency for Research on Cancer. 453 p
  • Li D, Wang M, Dhingra K, Hittelman W. 1996. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56: 287293.
  • London SJ, Stein EA, Henderson IC, Stampfer MJ, Wood WC, Remine S, Dmochowski JR, Robert NJ, Willett WC. 1992. Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 3: 503512.
  • Madigan M, Ziegler R, Benichou J, Byrne C, Hoover R. 1995. Proportion of breast cancer cases in United States explained by well-established risk factors. J Natl Cancer Inst 87: 16811685.
  • Mancini R, Romano G, Sgambato A, Flamini G, Giovagnoli M, Boninsegna A, Carraro C, Vecchione A, Cittadini A. 1999. Polycyclic aromatic hydrocarbon-DNA adducts in cervical smears of smokers and nonsmokers. Gynecol Oncol 75: 6871.
  • Mane S, Purnell D, Hsu I. 1990. Genotoxic effects of five polycyclic aromatic hydrocarbons in human and rat mammary epithelial cells. Environ Mol Mutagen 15: 7882.
  • Miller A. 1994. Hospital or population controls? It depends on the question. Prev Med 23: 263266.
  • Miller EC, Miller JA. 1981. Mechanisms of chemical carcinogenesis. Cancer 47: 10551064.
  • Motykiewicz G, Malusecka E, Grzybowska E, Chorazy M, Zhang YJ, Perera FP, Santella RM. 1995. Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes. Cancer Res 55: 14171422.
  • Parent N, Ghadirian P, Lacroix A, Perret C. 1997. The reliability of recollections of family history: implications for the medical provider. J Cancer Educ 12: 114120.
  • Pastides H, Kelsey J, Holford T, LiVolsi V. 1985. An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia. Am J Epidemiol 121: 440447.
  • Perera FP, Estabrook A, Hewer A, Channing KM, Rundle A, Mooney LA, Whyatt R, Phillips DH. 1995. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4: 233238.
  • Rundle A, Tang D, Hibshoosh H, Estabrook A, Schnabel F, Cao W, Grumet S, Della Rocca A, Perera F. 2000a. Genetic damage in breast tissue from polycyclic aromatic hydrocarbons is associated with breast cancer. Carcinogenesis 21: 12811289.
  • Rundle A, Tang D, Zhou J, Cho S, Perera F. 2000b. The association between glutathione-S-transferase-M1 genotype and polycyclic aromatic hydrocarbon (PAH)-DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev 9: 10791085.
  • Santella R. 1999. Immunological methods for detection of carcinogen-DNA damage in humans. Cancer Epidemiol Biomarkers Prev 8: 733739.
  • Shrout PE, Fleiss J. 1979. Intra-class correlations: uses in assessing rater reliability. Psychol Bull 86: 420428.
  • Wolff M, Toniolo P, Lee E, Rivera M, Dubin N. 1993. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85: 648652.
  • Zenzes M, Puy L, Bielecki R. 1998. Immunodetection of benzo[a]pyrene adducts in ovarian cells of women exposed to cigarette smoke. Mol Hum Reprod 4: 159165.
  • Zhang Y, Weksler B, Wang L, Schwartz J, Santella R. 1998. Immunohistochemical detection of polycyclic aromatic hydrocarbon-DNA damage in human blood vessels of smokers and non-smokers. Atherosclerosis 140: 325331.
  • Zheng T, Holford T, Mayne S, Tessari J, Owens P, Zahm S, Zhang B, Dubrow R, Ward B, Carter D, Boyle P. 1999. Environmental exposure to hexachlorobenzene (HCB) and risk of female breast cancer in Connecticut. Cancer Epidemiol Biomarkers Prev 8: 407411.